Literature DB >> 11847004

Phenotypic overlap between hematopoietic cells with suggested angioblastic potential and vascular endothelial cells.

Alexander Schmeisser1, Ruth H Strasser.   

Abstract

The existence of angioblast-like circulating endothelial progenitor cells (EPC) in adult humans has been suggested recently. Their role in postnatal angiogenesis is under intensive investigation. Discrimination between the supposed angioblasts (AC133(+)/FLK-1(+)/CD34(+)) and mature endothelial cells (ECs) is complicated by the fact that subsets of hematopoietic cells express markers similar to those of ECs. Among these, monocytes/macrophages and monocyte-derived dendritic cells (DCs) are more differentiated hematopoietic cell populations. They show a wide phenotypic overlap with particularly sinusoidal and microvascular ECs. Furthermore, under local angiogenic growth conditions, monocytes or monocyte precursors or immature DCs may differentiate into endothelial-like cells (ELC). Initial evidence suggests an endothelium-independent revascularization potential carried by macrophages. These macrophages have been shown to form "tunnel-like structures" in ischemic regions. Future studies will need to address the question of whether monocyte-/dendritic cell-derived ELC can develop a similar functional behavior in vasoregulation, coagulation, and fibrinolysis, as described for vascular ECs, and thus may contribute to neoangiogenesis by a direct vessel-forming role.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11847004     DOI: 10.1089/152581602753448540

Source DB:  PubMed          Journal:  J Hematother Stem Cell Res        ISSN: 1525-8165


  16 in total

1.  Temporary amniotic membrane patch for the treatment of primary pterygium: mechanisms of reducing the recurrence rate.

Authors:  Juan Ye; Koung Hoon Kook; Ke Yao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-09-17       Impact factor: 3.117

2.  Alteration in the gene expression pattern of primary monocytes after adhesion to endothelial cells.

Authors:  Sybill Thomas-Ecker; Antje Lindecke; Wolfgang Hatzmann; Christian Kaltschmidt; Kurt S Zänker; Thomas Dittmar
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-19       Impact factor: 11.205

3.  Intravitreal autologous bone marrow CD34+ cell therapy for ischemic and degenerative retinal disorders: preliminary phase 1 clinical trial findings.

Authors:  Susanna S Park; Gerhard Bauer; Mehrdad Abedi; Suzanne Pontow; Athanasios Panorgias; Ravi Jonnal; Robert J Zawadzki; John S Werner; Jan Nolta
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-12-09       Impact factor: 4.799

4.  A new method of culturing rat bone marrow endothelial progenitor cells in vitro.

Authors:  Zhaohong Kong; Meixin Chen; Jian Jiang; Jiang Zhu; Yumin Liu
Journal:  Cardiovasc Diagn Ther       Date:  2020-10

Review 5.  Endothelial function and endothelial progenitor cells in systemic lupus erythematosus.

Authors:  Anselm Mak; Jerry Kok Yen Chan
Journal:  Nat Rev Rheumatol       Date:  2022-04-07       Impact factor: 20.543

6.  Progenitor cells in healing after pterygium excision.

Authors:  Jeong Kyu Lee; Jae Chan Kim
Journal:  Yonsei Med J       Date:  2007-02-28       Impact factor: 2.759

Review 7.  The inflammatory response to skeletal muscle injury: illuminating complexities.

Authors:  Carine Smith; Maritza J Kruger; Robert M Smith; Kathryn H Myburgh
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

Review 8.  The chemokine system in arteriogenesis and hind limb ischemia.

Authors:  Paula K Shireman
Journal:  J Vasc Surg       Date:  2007-06       Impact factor: 4.268

Review 9.  Stem cells as potential therapeutic targets for inflammatory bowel disease.

Authors:  Udai P Singh; Narendra P Singh; Balwan Singh; Manoj K Mishra; Mitzi Nagarkatti; Prakash S Nagarkatti; Shree Ram Singh
Journal:  Front Biosci (Schol Ed)       Date:  2010-06-01

10.  In vitro characterization of circulating endothelial progenitor cells isolated from patients with acute coronary syndrome.

Authors:  Diana Campioni; Giorgio Zauli; Stefania Gambetti; Gianluca Campo; Antonio Cuneo; Roberto Ferrari; Paola Secchiero
Journal:  PLoS One       Date:  2013-02-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.